Balyasny Asset Management
CNST

Balyasny Asset Management’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Balyasny Asset Management’s Portfolio CNST Stock Details CNST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-639,674
Closed -$21.6M – 2665
2021
Q2 		$21.6M Buy
+639,674
New +$16.3M 0.1% 274

Balyasny Asset Management's CNST Position: Q3 2021 in Review

Balyasny Asset Management sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 639,674 shares — an estimated $21.6M sold.

Balyasny Asset Management first reported a position in CNST in Q2 2021 and held it in 1 quarter. The position peaked at $21.6M in Q2 2021. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

  • Balyasny Asset Management reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
  • Balyasny Asset Management sold 639,674 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $21.6M.
  • Balyasny Asset Management first reported a position in Constellation Pharmaceuticals, Inc. in Q2 2021 and held it in 1 quarter.
  • Balyasny Asset Management's Constellation Pharmaceuticals, Inc. position peaked at $21.6M in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on Balyasny Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.